Лекарственные поражения печени (клинические рекомендации для врачей). / Ивашкин, В.Т.; Барановский, Андрей Юрьевич; Райхельсон, Карина Леонидовна; Пальгова, Людмила Константиновна; Маевская, М.В.; Кондрашина, Элина Александровна; Марченко, Наталья Валерьевна; Некрасова, П.; Никитин, И.Г.
In: РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ, Vol. 29, No. 1, 2019, p. 85-115.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Лекарственные поражения печени (клинические рекомендации для врачей)
AU - Ивашкин, В.Т.
AU - Барановский, Андрей Юрьевич
AU - Райхельсон, Карина Леонидовна
AU - Пальгова, Людмила Константиновна
AU - Маевская, М.В.
AU - Кондрашина, Элина Александровна
AU - Марченко, Наталья Валерьевна
AU - Некрасова, П.
AU - Никитин, И.Г.
PY - 2019
Y1 - 2019
N2 - Aim. Clinical guidelines for the management of adult patients suffering from drug-induced liver injuries (DILI) are intended for all medical specialists, who treat such patients in their clinical practice. Key findings. The presented recommendations contain information about the epidemiological data, terminology, diagnostic principles, classification, prognosis and management of patients with DILI. The recommendations list pharmacological agents that most commonly cause DILI, including its fatal cases. Dose-dependent and predictable (hepatotoxic), as well as dose-independent and unpredictable (idiosyncratic) DILI forms are described in detail, which information has a particular practical significance. The criteria and types of DILI are described in detail, with the most reliable diagnostic and prognostic scales and indices being provided. The pathogenesis and risk factors for the development of DILI are considered. The clinical and morphological forms (phenotypes) of DILI are described. The diseases that are included into the differential diagnosis of DILI, as well as the principles of its implementation, are given. The role and significance of various diagnostic methods for examining a patient with suspected DILI is described, with the liver biopsy role being discussed. Clinical situations, in which DILI can acquire a chronic course, are described. A section on the assessment of causal relationships in the diagnosis of DILI is presented; the practical value of using the CIOMS-RUCAM scale is shown. All possible therapeutic measures and pharmacological approaches to the treatment of patients with various DILI phenotypes are investigated in detail. A particular attention is paid to the use of glucocorticosteroids in the treatment of DILI. Conclusion. The presented clinical recommendations are important for improving the quality of medical care in the field of hepatology.
AB - Aim. Clinical guidelines for the management of adult patients suffering from drug-induced liver injuries (DILI) are intended for all medical specialists, who treat such patients in their clinical practice. Key findings. The presented recommendations contain information about the epidemiological data, terminology, diagnostic principles, classification, prognosis and management of patients with DILI. The recommendations list pharmacological agents that most commonly cause DILI, including its fatal cases. Dose-dependent and predictable (hepatotoxic), as well as dose-independent and unpredictable (idiosyncratic) DILI forms are described in detail, which information has a particular practical significance. The criteria and types of DILI are described in detail, with the most reliable diagnostic and prognostic scales and indices being provided. The pathogenesis and risk factors for the development of DILI are considered. The clinical and morphological forms (phenotypes) of DILI are described. The diseases that are included into the differential diagnosis of DILI, as well as the principles of its implementation, are given. The role and significance of various diagnostic methods for examining a patient with suspected DILI is described, with the liver biopsy role being discussed. Clinical situations, in which DILI can acquire a chronic course, are described. A section on the assessment of causal relationships in the diagnosis of DILI is presented; the practical value of using the CIOMS-RUCAM scale is shown. All possible therapeutic measures and pharmacological approaches to the treatment of patients with various DILI phenotypes are investigated in detail. A particular attention is paid to the use of glucocorticosteroids in the treatment of DILI. Conclusion. The presented clinical recommendations are important for improving the quality of medical care in the field of hepatology.
UR - http://www.mendeley.com/research/druginduced-liver-injuries-clinical-guidelines-physicians
U2 - 10.22416/1382-4376-2019-29-1-101-131
DO - 10.22416/1382-4376-2019-29-1-101-131
M3 - статья
VL - 29
SP - 85
EP - 115
JO - РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ
JF - РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ
SN - 1382-4376
IS - 1
ER -
ID: 41113389